Dicerna Pharmaceuticals is a clinical-stage biopharmaceutical company that focuses on the discovery and development of treatments for rare inherited diseases.
ImmunityBio (formerly known as NantKwest) is a clinical-stage immunotherapy company focused on harnessing the power of the immune system using natural killer cells to treat cancer, infectious diseases, and inflammatory diseases.
Stoke Therapeutics is a developer of antisense oligonucleotide medicines that target ribonucleic acid (RNA) splicing to enhance gene expression for the treatment of genetic diseases.
CELLINK is a company that develops bioprinting technologies that allow researchers to 3D print human organs and tissue models of pharmaceutical and cosmetic products.
B.R.A.I.N. Biotechnology Research and Information Network develops enzymes, biocatalysts, and bioactive natural substances for manufacturers in the chemical and consumer goods industries.